HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.

AbstractBACKGROUND:
The prognostic significance of wait time between definite diagnosis and initial radical radiotherapy is not well established in patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) receiving both induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT).
METHODS:
From 2010 to 2018, 648 patients with LA-NPC treated with IC followed by CCRT were included.
RESULTS:
A total of 172 pairs of patients with LA-NPC were selected by propensity score matching (PSM). Compared to patients with an acceptable wait time (≤75 days), patients with a prolonged wait time (>75 days) had a significant lower 5-year DMFS rate (86.6% vs. 74.1%, p = 0.006). Subgroup analyses indicated that the unfavorable effects of longer waiting times were mainly seen among stage IVa patients.
CONCLUSIONS:
A prolonged wait time (>75 days) between definite diagnosis and initial radical radiotherapy has negative prognostic effects on patients with LA-NPC receiving IC plus CCRT, particularly those with IVa stage.
AuthorsYu-Ting Jiang, Kai-Hua Chen, Jie Yang, Zhong-Guo Liang, Song Qu, Ling Li, Xiao-Dong Zhu
JournalHead & neck (Head Neck) Vol. 44 Issue 5 Pg. 1182-1191 (05 2022) ISSN: 1097-0347 [Electronic] United States
PMID35218120 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 Wiley Periodicals LLC.
Chemical References
  • Cisplatin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chemoradiotherapy (adverse effects)
  • Cisplatin
  • Humans
  • Induction Chemotherapy
  • Nasopharyngeal Carcinoma (drug therapy, radiotherapy)
  • Nasopharyngeal Neoplasms (drug therapy, radiotherapy)
  • Prognosis
  • Waiting Lists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: